The CD16a isoform of the CD16 receptor (FcRγIII), expressed by NK cells and other immune cells, induces the ADCC pathway by binding multivalently to the Fc portion of IgG, which is bound to tumor-associated antigens on the surface of tumor cells [25,57]. The gene discussed is FCGR3A; the disease is neoplasm.